TEVA PHARMACEUTICAL INDUSTRIES LIMITED Other Asset Impairment Charges
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Other Asset Impairment Charges of $129.00 million for the 3-month period ending 2024-12-31, per its 10-K filed 2025-02-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2025-02-05
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED other asset impairment charges for the quarter ending 2024-12-31 was $129.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED other asset impairment charges for the quarter ending 2024-06-30 was $67.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED other asset impairment charges for the quarter ending 2024-03-31 was $577.00M.
| Period end | Other Asset Impairment Charges 3 month | Other Asset Impairment Charges 6 month | Other Asset Impairment Charges 9 month |
|---|---|---|---|
| 2024-12-31 | $129.00M 10-K · filed 2025-02-05 | ||
| 2024-06-30 | $67.00M 10-K · filed 2025-02-05 | $644.00M derived: sum of 2 quarters · filed 2025-02-05 | |
| 2024-03-31 | $577.00M 10-K · filed 2025-02-05 | ||
| 2013-09-30 | $26.00M 6-K · filed 2013-10-31 |